Neuronet convenes 6th meeting of its Scientific Coordination Board
On 22 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
EMIF
Alzheimer Europe sets out recommendations to improve data sharing in dementia research
Luxembourg, 23 February 2021 – At an online European Parliament workshop hosted by Deirdre Clune
Neuronet Working Group on sustainability holds an online meeting, sharing sustainability plans among projects
On 25 January, Neuronet hosted an online meeting of its WG on Sustainability, moderated by
Research Programme on Neurodegeneration Featured at Alzheimer Europe Conference
In 2019, the Neuronet Sessions introduced the projects of the Innovative Medicines Initiative (IMI) neurodegeneration
Neuronet Working Group on data sharing holds an online meeting, identifying key challenges and obstacles
The Neuronet Working Groups (WGs) are cross-project spaces for experts to discuss common issues, priorities
Proteomics analyses of CSF samples from EMIF-MBD study identify three different subtypes of Alzheimer’s disease
The EMIF multimodal biomarker (EMIF-MBD) study, led by researchers based at VUmc Amsterdam and Maastricht
EFPIA publishes a guest blog on IMI impact: collaboration is key to dementia challenge
On November 3rd, the European Federation of Pharmaceutical Industries and Associations (EFPIA) published a blog
Showcasing IMI projects: Neuronet at #30AEC
Neuronet has been designed to boost synergy and collaboration across the projects of the Innovative
Neuronet convenes annual event on European research collaboration in Alzheimer’s disease and beyond
Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together
Neuronet Scientific Coordination Board meeting brings together project leaders in The Hague
On 23 October (The Hague, Netherlands), Neuronet (Efficiently Networking European Neurodegeneration Research) convened the second